Nonetheless, Table 3 shows that only those in the group with a high level of inflammation, as measured by hs-CRP, presented a significant result for the development of ACD (adjusted HR = 11.33; 95% CI = 1.05 ~ 122.39; P = 0.046) in participants aged less than 65 years, but not in the group with high levels of both inflammation and hyperglycemia (P = 0.205) and the group with a high level of only HbA1c (P = 0.172). The gene discussed is CRP; the disease is Hyperglycemia.